Skip to main content
SpringerLink
Log in

The NMDA Receptor, NMDA Antagonists and Epilepsy Therapy

A Status Report

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Anderson WW, Lewis DA, Swartzwelder HS, Wilson WA. Magnesium-free medium activates seizure-like events in the rat hip-pocampal slice. Brain Research 398: 215–219, 1986

    PubMed  CAS  Google Scholar 

  • Aram JA, Martin D, Tomczyk M, Zeman S, Millar J, et al. Neocortical epileptogenesis in vitro: studies with N-methyl-D-as-partate, phencyclidine, sigma and dextromethorphan receptor ligands. Journal of Pharmacology and Experimental Therapeutics 248: 320–328, 1989

    PubMed  CAS  Google Scholar 

  • Avoli M, Louvel J, Pumain R, Oliver A. Seizure-like discharges induced by lowering [Mg++]o in the human epileptogenic neo-cortex maintained in vitro. Brain Research 417: 199–203, 1987

    PubMed  CAS  Google Scholar 

  • Baron BM, Harrison BL, Miller FP, McDonald, IA, Salituro FG, et al. Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site. Molecular Pharmacology 38: 554–561, 1990

    PubMed  CAS  Google Scholar 

  • Blake PA, Yamaguchi S, Thurkauf A, Rogawski MA. Anticon-vulsant 1-phenylcyclohexylamines: two analogues with low motor toxicity when orally administered. Epilepsia 33: 188–194, 1992

    PubMed  CAS  Google Scholar 

  • Bourn WM, Yang DJ, Davisson JN. Effect of ketamine enantiomers on sound-induced convulsions in epilepsy prone rats. Pharmacological Research Communications 15: 815–824, 1983

    PubMed  CAS  Google Scholar 

  • Carter C, Benayides J, Dana C, Schoemaker H, Perrault G, et al. Non-competitive NMDA receptor antagonists acting on the polymanine site. In Meldrum BS (Ed.) Excitatory amino acid antagonists, pp. 130–163, Blackwell Scientific, Oxford, 1991

    Google Scholar 

  • Carter C, Rivy J-P, Scatton B. Ifenprodil and SL 82.0715 are antagonists at the polyamine site of the N-methyl-D-aspartate (NMDA) receptor. European Journal of Pharmacology 164: 611–612, 1989

    PubMed  CAS  Google Scholar 

  • Chapman AG. Anticonvulsant activity of competitive N-methyl-D-aspartate antagonists following oral administration. In Meldrum BS, et al. (Eds) Excitatory Amino Acids, pp. 671–676, Raven Press, New York, 1991a

    Google Scholar 

  • Chapman AG. Excitatory amino acid antagonists and therapy of epilpesy. In Meldrum BS (Ed) Excitatory Amino Acid Antagonists, pp. 265–286, Blackwell Scientific, Oxford, 1991b

    Google Scholar 

  • Chapman AG, Meldrum BS. Non-competitive N-methyl-D-aspartate antagonists protect against sound-induced seizures in DBA/ 2 mice. Europ. J. Pharmacol. 166: 201–212, 1989

    CAS  Google Scholar 

  • Chen G, Bonner Anticonvusant properties of 1-(1-phenylcy-clohexyl)piperidine HCl and certain other drugs. Proc. Soc. Exp. Biol. Med. 106: 632–635, 1961

    PubMed  CAS  Google Scholar 

  • Chen H-SV, Pellegrini JW, Aggarwal SK, Lei SZ, Lipton SA. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. Journal of Neuroscience, in press, 1992

  • Chenard BL, Shalaby IA, Ronau RT, Butler TW, et al. Separation of α1; adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds. Journal of Medicinal Chemistry 34: 3085–3090, 1991

    PubMed  CAS  Google Scholar 

  • Childers Jr WE, Abou-Gharbia MA. 10,11-Dihydro-5-alkyl-12-substituted-10,5-(iminomethano)-5H-dibenzo [a,d]cycloheptenes as neuroprotective agents. US Patent 4 940 789, 1990

  • Clineschmidt BY, Martin GE, Bunting PR. Anticonvuslant activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo [a,d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug Development Research 2: 123–134, 1982

    CAS  Google Scholar 

  • Collingridge GL, Lester RAJ. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacological Reviews 40: 143–210, 1989

    Google Scholar 

  • Croucher MJ, Collins JF, Meldrum BS. Anticonvulsant action of excitatory amino acid antagonists. Science 216: 899–901, 1982

    PubMed  CAS  Google Scholar 

  • Davies J, Evans RH, Herding PL, Jones AW, Olverman HJ, Pook P, Watkins JC. CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]D-AP5 binding sites on brain membranes and anticonvulsant activity. Brain Research 382: 169–173, 1986

    PubMed  CAS  Google Scholar 

  • de Waele C, Vibert N, Baudrimont M, Vidal PP. NMDA receptors contribute to the resting discharge of vestibular neurons in the normal and hemilabyrinthectomized guinea pig. Experimental Brain Research 81: 125–133, 1990

    Google Scholar 

  • Dobson TA, Davis MA. 10,11-Dihydro-5,10-(iminomethano)-5H-dibenzo[a,d]cycloheptene and derivatives thereof. US Patent 3 597 433, 1971

  • Dobson TA, Davis MA. Substituted derivatives of 10,11-Dihdro-5,10-(iminomethano)-5H-dibenzocycloheptenes and preparation thereof. US Patent 3 716 541, 1973

  • Donevan SD, Jones, SM, Rogawski MA. Arcaine blocks N-methyl-D-aspartate receptor responses by an open channel mechanism: whole-cell and single-channel recording studies in cultured hippocampal neurons. Molecular Pharmacology 41: 727–735, 1992

    PubMed  CAS  Google Scholar 

  • Dunn RW, Corbett R, Martin LL, Payack JF, Laws-Ricker L, et al. Preclinical anxiolytic profiles of 7189 and 8319, novel non-competitive NMDA antagonists. In Current and future trends in anticonvulsant, anxiety, and stroke therapy, pp. 495–512, Wiley-Liss, New York, 1990

    Google Scholar 

  • Fielding S, Wilker JC, Chernack J, Ramirez V, Wilmot CA, et al. Preclinical anticonvulsant and neuroprotective profile of 8 319, a non-competitive NMDA antagonist. In Current and future trends in anticonvulsant, anxiety and stroke therapy, pp 533–541, Wiley-Liss, New York, 1990

    Google Scholar 

  • Fisher RS, Cysyk BJ, Lesser RP, Pontecorvo MJ, Ferkany JT, et al. Dextromethorphan for treatment of complex partial seizures. Neurology 40: 547–549, 1990

    PubMed  CAS  Google Scholar 

  • Ferkany JW, Kyle DJ, Willets J, Rzeszotarski WJ, Guzewska ME, et al. Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist. J. Pharmacol. Exp. Ther., 250: 100–109, 1989

    PubMed  CAS  Google Scholar 

  • Foster AC, Kemp JA. HA-966 antagonizes N-methyl-D-aspartate receptors through a selective interaction with the glycine modulatory site. Journal of Neuroscience 9: 2191–2196, 1989

    PubMed  CAS  Google Scholar 

  • Franklin PH, Murray TF. High affinity [3H]dextrorphan binding in rat brain is localised to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel. Molecular Pharmacology 41: 134–146, 1992

    PubMed  CAS  Google Scholar 

  • Garske GE, Palmer GC, Napier JJ, Griffith RC, Freedman LR, et al. Preclinical profile of the anticonvulsant remacemide and its enantiomers in the rat. Epilepsy Research 9: 161–174, 1991

    PubMed  CAS  Google Scholar 

  • Grant KA, Valverius P, Hudspith M, Tabakoff B. Ethanol withdrawal seizures and the NMDA receptor complex. European Journal of Pharmacology 176: 289–296, 1990

    PubMed  CAS  Google Scholar 

  • Grant KA, Snell LD, Rogawski MA, Thurkauf A, Tabakoff Comparison of the effects of the uncompetitive NMDA antagonist ADCI with its structural analogues dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures. J. Pharmacol. Exp. Ther. 260: 1017–1022, 1992

    PubMed  CAS  Google Scholar 

  • Grimwood S, Moseley AM, Carling RW, Leeson PD, Foster AC. Characterisation of the binding of [3H]L-689 560, an antagonist for the glycine site on the NMDA receptor, tq rat brain membranes. British Journal of Pharmacology 104 (Proceedings supplement): 74P, 1991

    Google Scholar 

  • Harrison BL, Baron BM, Cousino DM, McDonald IA. 4-[(Carboxymethyl)oxy]- and 4-[(carboxymethyl)amino]-5,7-dichloroquinoline-2-carboxylic acid: new antagonists of the strychnine-insensitive glycine binding site on the N-methyl-D-aspartate receptor complex. Journal of Medicinal Chemistry 33: 3130–3132, 1990

    PubMed  CAS  Google Scholar 

  • Henley JM, Johnston GAR. Vintage amino acid meeting describes new tools for amino acid research, subtypes of metabotropic receptors. Trends in Pharmacological Sciences 12: 357–358, 1991

    PubMed  CAS  Google Scholar 

  • Huettner JE. Competitive antagonists of glycine at the N-methyl-D-aspartate (NMDA) receptor. Biochemical Pharmacology 41: 9–16, 1991

    PubMed  CAS  Google Scholar 

  • Hutchison AJ, Williams M, Angst C, de Jesus R, Blanchard L, et al. 4-(Phosphonoalkyl)- and 4-phosphonoalkenyl)-2-piperidinecarboxylic acids: synthesis, activity at N-methyl-D-aspartic acid receptors, and anticonvulsant activity. Journal of Medicinal Chemistry 32: 2171–2178, 1989

    PubMed  CAS  Google Scholar 

  • Johnson G, Bigge CF. Recent advances in excitatory amino acid research. Ann. Rep. Med, Chem. 26: 11–22, 1991

    CAS  Google Scholar 

  • Johnson JW, Ascher P. Glycine potentiates the NMDA response of mouse central neurones. Nature 325: 529–531, 1987

    PubMed  CAS  Google Scholar 

  • Jones SM, Rogawski MA. The anticonvulsant (±)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10-imine (ADCI) selectively blocks NMDA-activated current in cultured rat hippocampal neurons: kinetic analysis and comparison with dizocilpine. Molecular Neuropharmacology, in press, 1992

  • Keana JF, McBurney RN, Scherz MW, Fischer JB, Hamilton PN, Smith SM, Server AC, Finkbeiner S, Stevens CF, Jahr C, Weber E. Synthesis and characterization of a series of diarylguanidines that are noncompetitive N-methyl-D-aspartate receptor antagonists with neuroprotective properties. Proceedings of the National Academy of Sciences USA 86: 5631–5635, 1989

    CAS  Google Scholar 

  • Kornhuber J, Bormann J, Hübers M, Rusche Riederer P. Effects of 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study. Euro. J. Pharmacol. 206: 297–300, 1991

    CAS  Google Scholar 

  • Kemp JA, Foster AC, Leeson PD, Priestley T, Tridgett R, et al. 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proceedings of the National Academy of Sciences USA 85: 6547–6550, 1988

    CAS  Google Scholar 

  • Kemp JA, Priestly T, Marshall GR, Leeson PD, Williams BJ. Functional assessment of the actions of 4-methyl derivatives of HA-966 at the glycine site of the N-methyl-D-aspartate receptor. British Journal of Pharmacology 102: 65P, 1990

    Google Scholar 

  • Kleckner NW, Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science 241: 835–837, 1988

    PubMed  CAS  Google Scholar 

  • Kk W, Colpaert FC. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects. Journal of Pharmacology and Experimental Therapeutics 252: 349–357, 1990

    Google Scholar 

  • Lapin S, Rogawski MA. Muscarinic antagonists attenuate dizocil-pine-induced hypermotility in mice. Life Sciences 50: PL59–PL64, 1992

    PubMed  CAS  Google Scholar 

  • Leander JD, Rathbun RC, Zimmerman DM. Anticonvulsant effects of phencyclidine-like drugs: Relation to N-methyl-D-as-partic acid antagonism. Brain Research 454: 368–372, 1988

    PubMed  CAS  Google Scholar 

  • Leeson PD, Baker R, Carling RW, Curtis NR, Moore KW, et al. Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor. Journal of Medicinal Chemistry 34: 1243–1252, 1991

    PubMed  CAS  Google Scholar 

  • Leeson PD, Carling RW, Smith JD, Baker R, Foster AC, et al. Trans-2-Carboxy-4-substituted tetrahydroquinolines. Potent glycine-site NMDA receptor antagonists. Medicinal Chemistry Research 1: 64–73, 1991

    CAS  Google Scholar 

  • Leeson PD, Williams BJ, Baker R, Ladduwahetty T, Moore KW, et al. Effects of five-membered ring conformation on bioreceptor recognition: Identification of 3R-amino-1-hydroxy-4R-methylpyrrolidin-2-on (L-687 414) as a potent glycine/N-methyl-D-aspartate receptor antagonist. Journal of the Chemical Society — Series Chemical Communications 22: 1578–1580, 1990

    Google Scholar 

  • Lehmann J, Hutchison AJ, McPherson SE, Mondadori C, Schmutz M, et al. CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist. J. Pharmacol. Exp. Ther. 246: 65–75, 1988

    PubMed  CAS  Google Scholar 

  • Legendre P, Westbrook GL. Ifenprodil blocks N-methyl-D-aspartate receptors by a two-component mechanism. Molecular Pharmacology 40: 289–298, 1991

    PubMed  CAS  Google Scholar 

  • Leppik IE, Marienau K, Graves NM, Rask CA. MK-801 for epilepsy: a pilot study. Neurology 38 (Suppl. 1): 405, 1988

    Google Scholar 

  • Liljequist S. The competititive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures. European Journal of Pharmacology 192: 197–198, 1991

    PubMed  CAS  Google Scholar 

  • Lüscher W, Hünack D. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J. Pharmacol. Exp. Ther. 256: 432–440, 1991a

    Google Scholar 

  • Lüscher W, Hünack D. The novel competitive N-methyl-D-aspartate antagonist CGP 37849 preferentially induces phency-clidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin 1A receptors. J. Pharmacol. Exp. Ther. 257: 1146–1153, 1991b

    Google Scholar 

  • MacDonald JF, Bartlett MC, Mody I, Pahapill P, Reynolds JN, et al. Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones. Journal of Physiology (London) 432: 483–508, 1991

    CAS  Google Scholar 

  • McLean MJ, Gupta RC, Dettbarn WD, Wamil AW. Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the rat. Toxicology and Applied Pharmacology 112: 95–103, 1992

    PubMed  CAS  Google Scholar 

  • Mansbach RS, Balster RL. Pharmacologial specificity of the phencyclidine discriminative stimulus in rats. Pharmacology Biochemistry and Behavior 39: 971–975, 1991

    CAS  Google Scholar 

  • Marvizón JCG, Lewin AH, Skolnick P. 1-Aminocyclopropane car-boxylic acid: a potent and selective ligand for the glycine mod-ulatory site of the N-methyl-D-aspartate receptor complex. Journal of Neurochemistry 52: 992–994, 1989

    PubMed  Google Scholar 

  • McNamara JO, Rigsbee LC, Butler LS, Shin Intravenous phenytoin is an effective anticonvulsant in the kindling model. Annals of Neurology 26: 675–678, 1989

    PubMed  CAS  Google Scholar 

  • Meguro H, Mori H, Araki K, Kushiya E, Kutsuwada T, et al. Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature 357: 70–74, 1992

    PubMed  CAS  Google Scholar 

  • Meldrum BS, Turski L, Schwarz M, Dzuczwar SJ, Sontag KH. Anticonvulsant action of 1,3-dimethyl-5-aminoadamantane. Pharmacological studies in rodents and baboon, Papio papio. Naunyn-Schmiedeberg’s Archives of Pharmacology 332: 93–97, 1986

    PubMed  CAS  Google Scholar 

  • Mody I, Lambert JD. Low extracellular magnesium induces epi-leptiform activity and spreading depression in rat hippocampal slices. Journal of Neurophysiology 57: 896–888, 1987

    Google Scholar 

  • Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, et al. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256: 1217–1221, 1992

    PubMed  CAS  Google Scholar 

  • Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, et-al. Molecular cloning and characterization of the rat NMDA receptor. Nature 354: 31–37, 1991

    PubMed  CAS  Google Scholar 

  • Morrisett RA, Rezvani AH, Overstreet D, Janowsky DS, Wilson WA, Swartzwelder S. MK-801 powerfully inhibits alcohol withdrawal seizures in rats. European Journal of Pharmacology 176: 103–105, 1990

    PubMed  CAS  Google Scholar 

  • Olney JW, Labruyere J, Price MT. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244: 1360–1362, 1989

    PubMed  CAS  Google Scholar 

  • Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA. NMDA antagonist neurotoxicity: mechanism and prevention. Science 254: 1515–1518, 1991

    PubMed  CAS  Google Scholar 

  • Ornstein PL, Schoepp DD, Leander JD, Lodge D. The development of novel competitive N-methyl-D-aspartate antagonists as useful therapeutic agents. In Meldrum et al. (Eds) Excitatory amino acids, pp. 415–423, Raven Press, New York, 1991

    Google Scholar 

  • Palfreyman MG, Baron BM. Non-competitive NMDA antagonists, acting on the glycine site. In Meldrum BS; (Ed.) Excitatory amino acid antagonists, pp. 101–129, Blackwell Scientific Publications, Oxford, 1991

    Google Scholar 

  • Patel S, Chapman AG, Graham JL, Meldrum BS, Frey P. Anticonvulsant activity of the NMDA antagonists, D(-)4-(3-phos-phonopropyl)piperazine-2-carboxylic acid (D-CPP) and D(-)(E)-4-(3-phosphonoprop-2-enyl)piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy. Epilepsy Research 7: 3–10, 1990

    PubMed  CAS  Google Scholar 

  • Perrault G, Morel E, Sanger DJ, Zivkovic Comparison of the pharmacological profiles of four NMDA antagonists ifenprodil, SL-82-0715, MK-801 and CPP in mice. British Journal of Pharmacology 97 (Suppl.): 580P, 1989

    Google Scholar 

  • Peterson DW, Collins JF, Bradford HF. The kindled amygdala model of epilepsy: Anticonvulsant action of amino acid antagonists. Brain Research 275: 169–172, 1983

    PubMed  CAS  Google Scholar 

  • Pontecorvo MJ, Karbon EW, Goode S, Clissold DB, Borosky SA, et al. Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents. Brain Research Bulletin 26: 461–465, 1991

    PubMed  CAS  Google Scholar 

  • Ransom RW. Polyamine and ifenprodil interactions with the NMDA receptor’s glycine site. European Journal of Pharmacology — Molecular Pharmacology Section 208: 67–71, 1991

    PubMed  CAS  Google Scholar 

  • Ray R, Julien R, Gordon J, Blosser J. FPL 12495, a metabolite of remacemide, is a noncompetitive NMDA antagonist. Society for Neuroscience Abstracts 17: 391, 1991

    Google Scholar 

  • Reddy NL, Hu L-Y, Fischer JB, McBurney RN, Weber E, et al. Synthesis and structure-activity relationships of N-alkyl and N,N′-dialkyl substituted N,N′-diarylguanidines as non competitive NMDA antagonists. Abstr. Am. Chem. Soc. 202: MEDI 147, 1991

    Google Scholar 

  • Reynolds IJ. Arcaine is a competitive antagonist of the polyamine site on the NMDA receptor. European Journal of Pharmacology 177: 215–216, 1990

    PubMed  CAS  Google Scholar 

  • Reynolds IJ, Baron BM, Edwards ML. 1,10-bis(Guanidino)decane inhibits N-methyl-D-aspartate responses in vitro and in vivo. Journal of Pharmacology and Experimental Therapeutics 259: 626–632, 1991

    PubMed  CAS  Google Scholar 

  • Reynolds IJ, Miller RJ. Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines. Molecular Pharmacology 36: 758–765, 1989

    PubMed  CAS  Google Scholar 

  • Rock DM, Macdonald RL. The polyamine spermine has multiple action on N-methyl-D-aspartate receptor single-channel currents in cultured cortical neurons. Molecular Pharmacology 41: 83–88, 1991

    Google Scholar 

  • Rogawski MA, Porter RJ. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacological Reviews 42: 224–286, 1990

    Google Scholar 

  • Rogawski MA, Thurkauf A, Yamaguchi S, Rice Jacobson AE, et al. Anticonvulsant activities of 1-phenylcyclohexylamine and its conformationally restricted analogue 1,1-pentamethylene te-trahydro isoquinoline. Journal of Pharmacology and Experimental Therapeutics 249: 708–712, 1989

    PubMed  CAS  Google Scholar 

  • Rogawski MA, Yamaguchi S, Jones SM, Rice K, Thurkauf A, et al. Anticonvulsant activity of the low-affinity uncompetitive N-methyl-D-aspartate antagonist (±)-5-aminocarbonyl-10,11-dih-ydro-5H-dibenzo[a,d]cyclohepten-5, 10-imine (ADCI): comparison with the structural analogues dizocilpine (MK-801) and carbamazepine. Journal of Pharmacology and Experimental Therapeutics 259: 30–37, 1991

    PubMed  CAS  Google Scholar 

  • Rogawski MA, Yamaguchi S, Blake PA, Jones SM, Bieda M, et al. Anticonvulsant 1-phenylcycloalkylamine analogues: uncompetitive NMDA antagonists with low motor toxicity. In Kamenka J-M & Domino EF (Eds) Multiple sigma and PCP receptor ligands: mechanisms for neuromodulation and neuroprotection? pp. 747–758, NPP Books, Ann Arbor, MI, 1992

    Google Scholar 

  • Romano C, Williams K, Molinoff PB. Polyamines modulate the binding of [3H]MK-801 to the solubilized N-methyl-D-aspartate receptor. Journal of Neurochemistry 57: 811–818, 1991

    PubMed  CAS  Google Scholar 

  • Sakurai SY, Cha JH, Penny JB, Young AB. Regional distribution and properties of [3H]MK-801 binding sites determined by quantitative autoradiography in rat brain. Neuroscience 40: 533–543, 1991

    PubMed  CAS  Google Scholar 

  • Salituro FG, Harrison BL, Baron BM, Nyce PL, Stewart KT, McDonald IA. 3-(2-carboxyindol-3-yl)propionic acid derivatives: antagonists of the strychnine-insensitive glycine receptor associated with the N-methyl-D-aspartate receptor complex. Journal of Medicinal Chemistry 33: 2944–2946, 1990

    PubMed  CAS  Google Scholar 

  • Salt TE, Eaton SA. Function of non-NMDA receptors and NMDA receptors in synaptic responses to natural somatosensory stimulation in the ventrobasal thalamus. Experimental Brain Research 77: 646–652, 1989

    CAS  Google Scholar 

  • Saywell K, Singh L, Oles RJ, Vass C, Leeson PD, et al. The anticonvulsant properties in the mouse of the glycine/NMDA receptor antagonist, L-687,414. British Journal of Pharmacology 102: 66P, 1990

    Google Scholar 

  • Schmutz M, Portet Jeker A, Klebs K, Vassout A, et al. The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents. Naunyn-Schmiedeberg’s Archives of Pharmacology 342: 61–66, 1990

    PubMed  CAS  Google Scholar 

  • Schmutz M, Jeker A, Klebs K, Portet C, Pozza M, et al. CGP 40116/ CGP 43487: competitive N-methyl-D-aspartate receptor antagonists with potent oral anticonvulsant activity. Epilepsia 32 (Suppl. 1): 59, 1991

    Google Scholar 

  • Schoepp DD, Gamble AY, Salhoff CR, Johnson BG, Ornstein PL. Excitatory amino acid-induced convulsions in neonatal rats mediated by distinct receptor subtypes. European Journal of Pharmacology 182: 421–427, 1990a

    PubMed  CAS  Google Scholar 

  • Schoepp DD, Ornstein PL, Leander JD, Lodge D, Salhoff CR, et al. Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspar-tic acid antagonist with a short duration of action. J. Pharmacol, Exp. Therap. 255: 1301–1308, 1990b

    CAS  Google Scholar 

  • Schoepp DD, Ornstein PL, Salhoff CR, Leander JD. Neuroprotective effects of LY274614, a structurally novel systemically active competitive NMDA receptor antagonist. Journal of Neural Transmission General Section 85: 131–143, 1991

    PubMed  CAS  Google Scholar 

  • Sharp FR, Jasper P, Hall J, Noble L, Sager SM. MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Annals of Neurology 30: 801–809, 1991

    PubMed  CAS  Google Scholar 

  • Sillito AM, Murphy PC, Salt TE, Moody CI. Dependence of retinogeniculate transmission in cat on NMDA receptors. Journal of Neurophysiology 63: 347–355, 1990

    PubMed  CAS  Google Scholar 

  • Singh L, Donald AE, Foster AC, Hutson PH, Iversen LL, et al. Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent γ-butyrolactone-like sedative. Proc. Nat. Acad. Sci. USA 87: 347–351, 1990a

    PubMed  CAS  Google Scholar 

  • Singh L, Oles RJ, Tricklebank MD. Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex. British Journal of Pharmacology 99: 285–288, 1990b

    PubMed  CAS  Google Scholar 

  • Singh L, Oles RJ, Vass CA, Woodruff GN. A slow intravenous infusion of N-methyl-DL-aspartate as a seizure model in the mouse. Journal of Neuroscience Methods 37: 227–232, 1991

    PubMed  CAS  Google Scholar 

  • Skolnick P, Marvizón JCG, Jackson BW, Monn JA, Rice K et al. Blockade of N-methyl-D-aspartate induced convulsions by 1-aminocyclopropane-carboxylates. Life Sciences 45: 1647–1655, 1989

    PubMed  CAS  Google Scholar 

  • Smith, JC, Feldman JL, Schmidt BJ. Neural mechanisms generating locomotion studied in mammalian brain stem-spinal cord in vitro. FASEB Journal 2: 2283–2288, 1988

    PubMed  CAS  Google Scholar 

  • Smith SE, Meldrum BS. The glycine-site NMDA receptor antagonist, R-(+)-cis-β-methyl-3-amino-1-hydroxypyrrolid-2-one, L-687,414 is anticonvulsant in baboons. European Journal of Pharmacology 21: 109–111, 1992

    Google Scholar 

  • Stagnitto ML, Palmer GC, Ordy JM, Griffith RC, Napier JJ, et al. Preclinical profile of remacemide: a novel anticonvulsant effective against maximal electroshock seizures in mice. Epilepsy Research 7: 11–28, 1990

    PubMed  CAS  Google Scholar 

  • Steinberg GK, Bell, T. Clinical dose-escalation safety study of the NMDA antagonist, dextromethorphan in neurosurgical patients. Stroke 22: 141, 1992

    Google Scholar 

  • Thurkauf A, de Costa BR, Yamaguchi S, Mattson MV, Jacobson AE, et al. Synthesis and anticonvulsant activity of 1-phenyl-cyclohexylamine analogues. Journal of Medicinal Chemistry 33: 1452–1458, 1990

    PubMed  CAS  Google Scholar 

  • Troupin AS, Mendius, Cheng F, Risinger MW. MK-801. In New Anticonvulsant Drugs, ed. by Meldrum BS, Porter RJ, pp. 191–201, John Libbey, London, 1986

    Google Scholar 

  • Tortella FC, Ferkany JW, Pontecorvo MJ. Anticonvulsant effects of dextrorphan in rats: possible involvement in dextromethor-phan-induced seizure protection. Life Sciences 42: 2509–2514, 1988

    PubMed  CAS  Google Scholar 

  • Vartanian MG, Taylor CP. Different stereoselectivity of the enantiomers of HA-966 (3-amino-1-hydroxy-2-pyrrolidinone) for neuroprotective and anticonvulsant actions in vivo. Neuroscience Letters 133: 109–112, 1991

    PubMed  CAS  Google Scholar 

  • Walton NY, Treiman DM. Motor and electroencephalographic response of refractory experimental status epilepticus in rats to treatment with MK-801, diazepam, or MK-801 plus diazepam. Brain Research 553: 97–104, 1991

    PubMed  CAS  Google Scholar 

  • Watson GB, Lanthorn TH. Pharmacological characteristics of cyclic homologues of glycine at the N-methyl-D-aspartate receptor-associated glycine site. Neuropharmacology 29: 727–730, 1990

    PubMed  CAS  Google Scholar 

  • Watkins JC. Some chemical highlights in the development of excitatory amino acid pharmacology. Canadian Journal of Physiology and Pharmacology 69: 1064–1075, 1991

    PubMed  CAS  Google Scholar 

  • Weber E, Keana JFW, Barmettler P. PCP receptor ligands and the use thereof. US Patent 5 011 834, 1991

  • Whitten JP, Baron BM, Muench D, Miller F, White HS, et al. (R) -4-Oxo-5-phosphononorvaline: a new competitive glutamate agtagonist at the NMDA receptor complex. Journal of Medicinal Chemistry 33: 2961–2963, 1990

    PubMed  CAS  Google Scholar 

  • Willetts J, Balster RL, Leander JD. The behavioral pharmacology of NMDA receptor antagonists. Trends in Pharmacological Sciences 11: 423–428, 1990

    PubMed  CAS  Google Scholar 

  • Williams K, Dawson VL, Romano C, Dichter MA, Molinoff, PB. Characterization of polyamines having agonist, antagonist and inverse agonist effects at the polyamine recognition site of the NMDA receptor. Neuron 5: 199–208, 1990

    PubMed  CAS  Google Scholar 

  • Williams K, Romano C, Dichter MA, Molinoff PB. Modulation of the NMDA receptor by polyamines. Life Sciences 48: 469–498, 1991

    PubMed  CAS  Google Scholar 

  • Williams K, Romano C, Molinoff PB. Effects of polyamines on the binding of [3H]MK801 to the N-methyl-D-aspartate receptor: pharmacological evidence for the existence of a polyamine recognition site. Molecular Pharmacology 36: 575–581, 1989.

    PubMed  CAS  Google Scholar 

  • Wong BY, Coulter DA, Choi DW, Prince DA. Dextrorphan and dextromethorphan common antitussives are antiepileptic and antagonize N-methyl-D-aspartate in brain slices. Neuroscience Letters 85: 261–266, 1988

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuronal Excitability Section, Epilepsy Research Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Building 10, Room 5c-205, Bethesda, Maryland, MD 20892, USA

    Michael A. Rogawski

Authors
  1. Michael A. Rogawski
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rogawski, M.A. The NMDA Receptor, NMDA Antagonists and Epilepsy Therapy. Drugs 44, 279–292 (1992). https://doi.org/10.2165/00003495-199244030-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199244030-00001

Keywords

Search

Navigation